Matches in Wikidata for { <http://www.wikidata.org/entity/Q43251299> ?p ?o ?g. }
- Q43251299 description "2010 nî lūn-bûn" @default.
- Q43251299 description "2010年の論文" @default.
- Q43251299 description "2010年学术文章" @default.
- Q43251299 description "2010年学术文章" @default.
- Q43251299 description "2010年学术文章" @default.
- Q43251299 description "2010年学术文章" @default.
- Q43251299 description "2010年学术文章" @default.
- Q43251299 description "2010年学术文章" @default.
- Q43251299 description "2010年學術文章" @default.
- Q43251299 description "2010年學術文章" @default.
- Q43251299 description "2010年學術文章" @default.
- Q43251299 description "2010年學術文章" @default.
- Q43251299 description "2010年學術文章" @default.
- Q43251299 description "2010년 논문" @default.
- Q43251299 description "article científic" @default.
- Q43251299 description "article scientific" @default.
- Q43251299 description "article scientifique" @default.
- Q43251299 description "articol științific" @default.
- Q43251299 description "articolo scientifico" @default.
- Q43251299 description "artigo científico" @default.
- Q43251299 description "artigo científico" @default.
- Q43251299 description "artigo científico" @default.
- Q43251299 description "artikel ilmiah" @default.
- Q43251299 description "artikull shkencor" @default.
- Q43251299 description "artikulong pang-agham" @default.
- Q43251299 description "artykuł naukowy" @default.
- Q43251299 description "artículo científico publicado en 2010" @default.
- Q43251299 description "artículu científicu espublizáu en 2010" @default.
- Q43251299 description "bilimsel makale" @default.
- Q43251299 description "bài báo khoa học" @default.
- Q43251299 description "naučni članak" @default.
- Q43251299 description "scienca artikolo" @default.
- Q43251299 description "scientific article published in January 2010" @default.
- Q43251299 description "scientific article published in January 2010" @default.
- Q43251299 description "scientific article published in January 2010" @default.
- Q43251299 description "teaduslik artikkel" @default.
- Q43251299 description "tieteellinen artikkeli" @default.
- Q43251299 description "tudományos cikk" @default.
- Q43251299 description "vedecký článok" @default.
- Q43251299 description "vetenskaplig artikel" @default.
- Q43251299 description "videnskabelig artikel" @default.
- Q43251299 description "vitenskapelig artikkel" @default.
- Q43251299 description "vitskapeleg artikkel" @default.
- Q43251299 description "vědecký článek" @default.
- Q43251299 description "wetenschappelijk artikel" @default.
- Q43251299 description "wissenschaftlicher Artikel" @default.
- Q43251299 description "επιστημονικό άρθρο" @default.
- Q43251299 description "мақолаи илмӣ" @default.
- Q43251299 description "наукова стаття, опублікована в січні 2010" @default.
- Q43251299 description "научна статия" @default.
- Q43251299 description "научная статья" @default.
- Q43251299 description "научни чланак" @default.
- Q43251299 description "научни чланак" @default.
- Q43251299 description "מאמר מדעי" @default.
- Q43251299 description "مقالة علمية نشرت في يناير 2010" @default.
- Q43251299 description "জানুয়ারি ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q43251299 description "บทความทางวิทยาศาสตร์" @default.
- Q43251299 description "სამეცნიერო სტატია" @default.
- Q43251299 name "Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: results of a randomised trial (GABG-IV E-93) - the German Adjuvant Breast Cancer Group" @default.
- Q43251299 name "Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: results of a randomised trial" @default.
- Q43251299 type Item @default.
- Q43251299 label "Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: results of a randomised trial (GABG-IV E-93) - the German Adjuvant Breast Cancer Group" @default.
- Q43251299 label "Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: results of a randomised trial" @default.
- Q43251299 prefLabel "Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: results of a randomised trial (GABG-IV E-93) - the German Adjuvant Breast Cancer Group" @default.
- Q43251299 prefLabel "Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: results of a randomised trial" @default.
- Q43251299 P1433 Q43251299-79A57C60-A48E-4291-86BB-6B0A8F4A2171 @default.
- Q43251299 P1476 Q43251299-D8D7BCAF-4930-4201-9AB4-D0C3FAA1D686 @default.
- Q43251299 P2093 Q43251299-21E0944F-8E57-4E64-B068-205A3DE79E22 @default.
- Q43251299 P2093 Q43251299-9239A1E1-6185-40BD-A30D-3FB430F2C84B @default.
- Q43251299 P2093 Q43251299-92EB4F1B-F853-43AE-9E88-6753001D0F02 @default.
- Q43251299 P2093 Q43251299-A648EF6B-625F-45E2-B0A6-AA7A9C726A6D @default.
- Q43251299 P2093 Q43251299-B47CD1EC-E25D-4E7E-958C-8469D91C67CF @default.
- Q43251299 P2093 Q43251299-CA2BB986-D91D-46D3-8C06-8BF4092F1A28 @default.
- Q43251299 P2093 Q43251299-CBCF0BFD-7C45-490D-AF43-87CFA327BBD9 @default.
- Q43251299 P2093 Q43251299-D4A8BCA5-03B2-4A91-9B29-0AAA3EE39D38 @default.
- Q43251299 P2093 Q43251299-DFB53F22-D2DC-4929-9F97-75C90A775DDB @default.
- Q43251299 P2093 Q43251299-F98C3F62-F175-453A-85E4-2DF0CC88D847 @default.
- Q43251299 P2093 Q43251299-FDB6206C-B27C-4F76-8067-BE0F0224F6F1 @default.
- Q43251299 P2283 Q43251299-394224D1-F783-4B82-8A66-7009F1618A16 @default.
- Q43251299 P304 Q43251299-57FCAE7B-072E-44E2-A420-78CF41E39075 @default.
- Q43251299 P31 Q43251299-4A60CB45-93F8-4987-A1B8-DD5E5DB3BCCE @default.
- Q43251299 P356 Q43251299-FC65457E-6807-4721-BFA2-B46A84471185 @default.
- Q43251299 P433 Q43251299-9AE19C1D-E8F6-4E3E-9B14-4545BCDC7C2D @default.
- Q43251299 P478 Q43251299-1D59B5DF-3C75-47E4-8931-B85EE946EA20 @default.
- Q43251299 P50 Q43251299-14C933C3-8DED-41A5-BCC7-AC2080E5DD0D @default.
- Q43251299 P577 Q43251299-82A17C8F-7BC1-4057-AC70-58F48919C08A @default.
- Q43251299 P698 Q43251299-86DD1B62-02AB-452A-A3B3-4929E44CAC82 @default.
- Q43251299 P921 Q43251299-4D084B71-B72D-4E2F-A468-6E8CE3E532E0 @default.
- Q43251299 P356 J.EJCA.2009.10.001 @default.
- Q43251299 P698 19879750 @default.
- Q43251299 P1433 Q332260 @default.
- Q43251299 P1476 "Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: results of a randomised trial (GABG-IV E-93) - the German Adjuvant Breast Cancer Group" @default.
- Q43251299 P2093 "Bettina Conrad" @default.
- Q43251299 P2093 "Beyhan Ataseven" @default.
- Q43251299 P2093 "Erika Graf" @default.
- Q43251299 P2093 "German Adjuvant Breast Cancer Group" @default.
- Q43251299 P2093 "Gunter von Minckwitz" @default.
- Q43251299 P2093 "Heidi Massinger-Biebl" @default.
- Q43251299 P2093 "Jörn Hilfrich" @default.
- Q43251299 P2093 "Manfred Kaufmann" @default.